Based on ROC analysis, we concluded that HSPA1A/B gene expression cannot significantly distinguish PD from HD and an elevated level of HSPA6 mRNA or intracellular p62 protein level alone may not be considered as reliable PD biomarkers because of insufficient specificity (Supplementary Figure S4, Figure 4a,b). The gene discussed is HSPA6; the disease is Huntington disease.